Phase II study of brigatinib in patients with TKI-naive ROS1rearranged non-small cell lung cancer (NSCLC): Barossa study
Toshiaki Takahashi,Seiji Niho,Ryo Toyozawa,Yasushi Goto,Kadoaki Ohashi,Haruko Daga,Hiroshi Tanaka,Yoshihiro Hattori,Masahiro Morise,Jun Sakakibara-Konishi,Masahiro Kodani,Takaya Ikeda,Shingo Matsumoto,Kiyotaka Yoh,Shogo Nomura,Koichi Goto ANNALS OF ONCOLOGY（2023）
AI 理解论文
溯源树
样例
